Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III).
By J. Hollowell, N. Staehling, W. Flanders, W. H. Hannon, E. Gunter, C. Spencer, L. Braverman. Journal of Clinical Endocrinology and Metabolism, 2002
3,877 citations recorded by the source corpus.
Subfields: Endocrinology, Diabetes and Metabolism
View Paper: https://www.semanticscholar.org/paper/c9c39a83fdcfa4de7404569f666f8e2cd897a8ad
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Endocrinology, Diabetes and Metabolism
Citations in the corpus
- Hashimoto thyroiditis: clinical and diagnostic criteria. (2014, background): “The prevalence is 8 cases per 1000 when estimated from a review of published articles [1], and 46 cases per 1000 when estimated from the biochemical evidence of hypothyroidism and thyroid autoantibodies in subjects participating to the 3rd National Health and Nutrition Examination Survey [20].”
- Subclinical Hypothyroidism and the Risk of Coronary Heart Disease and Mortality (2010, background): “Whickham Survey,17,18 1996, 2010 Adults living in and near Newcastle upon Tyne, England 2406 46 (18-92) 1284 (53.”
- Clinical Practice Guidelines for Hypothyroidism in Adults: Cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association (2012, positive): “Only positive TPOAb tests were significantly associated with hypothyroidism (11).”
- The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis. (2014, background): “%) that in the United States, with nearly the same percentage of clinical hyperthyroidism (35.8% in Europe).”
- Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. (2004, background): “2% of the population is defined as having subclinical hyperthyroidism.(23) If patients with known thyroid disease are excluded, the prevalence decreases to 2%.”
- Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement (2014, positive): “LT3-only therapy should be monitored with measurements of fasting serum TSH levels before the administration of the dose, aiming to target serum TSH within the lower tertile of the reference range, if aiming for TSH values seen in a normal population (54).”